Clinical Trial

A Phase 1 Study to Evaluate Pharmacokinetics, Safety and Tolerability of ZL-1503 in Healthy Volunteers

Name: A Phase 1 Study to Evaluate Pharmacokinetics, Safety and Tolerability of ZL-1503 in Healthy Volunteers — clinical trial record (NCT07658482)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This is a phase 1, single dose, randomized, open-label, parallel-group study to evaluate the pharmacokinetics (PK), safety, tolerability and immunogenicity of ZL-1503 and to explore its PD biomarkers following a single subcutaneous (SC) or intravenous (IV) administration in healthy volunteers.

Trial Details

NCT Number	NCT07658482
Lead Sponsor	Zai Lab (Shanghai) Co., Ltd.
Conditions	Healthy Volunteers
Enrollment	36 participants
Start Date	2026-09-03
Primary Completion	2027-02-06 (estimated)
Study Completion	2027-11-10 (estimated)
Updated on ClinicalTrials.gov	2026-06-22